Company Filing History:
7 out of 363 
5 out of 2,078 
1 out of 32 
Years Active: 2004-2012
Title: The Innovative Legacy of Bruce Ray Conway
Introduction:
Bruce Ray Conway, a talented inventor hailing from Doylestown, PA (US), has made significant contributions to the field of pharmaceuticals with a total of 14 patents to his name. His groundbreaking work has revolutionized the treatment of diabetes and Syndrome X.
Latest Patents:
1. "Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators" - This patent showcases a novel combination therapy involving PPAR modulators and glucose reabsorption inhibitors for effectively treating diabetes and Syndrome X.
2. "Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators" - Another cutting-edge patent by Conway, demonstrating the use of RXR modulators and glucose reabsorption inhibitors for the treatment of diabetes and Syndrome X.
Career Highlights:
Conway's expertise and innovation were honed during his tenure at esteemed pharmaceutical companies like Ortho-McNeil Pharmaceutical Corp and Janssen Pharmaceutica Nv. His keen insights and pioneering spirit have led to the development of groundbreaking therapies in the pharmaceutical industry.
Collaborations:
Throughout his career, Conway had the privilege of working alongside esteemed colleagues such as Bruce E Maryanoff and Keith T Demarest. This collaborative effort has undoubtedly facilitated the exchange of ideas and the implementation of innovative solutions in the realm of pharmaceutical research and development.
Conclusion:
In conclusion, Bruce Ray Conway's remarkable journey as an inventor has left an indelible mark on the field of pharmaceuticals. His relentless pursuit of excellence and unwavering commitment to innovation continue to inspire future generations of inventors and researchers in their quest to make the world a healthier place.